Neos Therapeutics (NSDQ:NEOS) won FDA approval yesterday for its controlled-release formulation of an old ADHD drug, methylphenidate.
The company touts its product, Cotempla XR-ODT, as the 1st methylphenidate tablet designed to release medication over time instead of all at once.
Get the full story at our sister site, Drug Delivery Business News.
The post Controlled-release ADHD drug wins FDA approval appeared first on MassDevice.
from MassDevice http://ift.tt/2sT2Ptc
Cap comentari:
Publica un comentari a l'entrada